Atlas Trials

Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study

Clinical trial NCT03901690 · UNKNOWN

Trial details

NCT number
NCT03901690
Sponsor
Centro de Investigaciones Medicas y Ensayos Clinicos Dr Italo Fabbri
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Genital Wart Virus Infection
Start date
2019-08-27
Primary completion
2020-03-10
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.